Evidence has accumulated that disruption of our body’s internal clock (the so-called circadian clock) might contribute to the development of Type 2 diabetes and other cardiometabolic complications.

Few studies have investigated the link between the disruption of the daily sleep-wake pattern and Type 2 diabetes in man. For this reason, a multi-disciplinary consortium of leading academic experts and research-intensive SME’s have joined forces under EuRhythDia, the Consortium on chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population. This 5-year project will look at whether lifestyle change to reset the internal clock can significantly reduce the risk of developing Type 2 diabetes and cardiometabolic complications. 

Principal investigator: Prof Rainer Böger

Past event(s):

24 May 2017- Workshop at the German Diabetes Congress, Hamburg, Germany 

June 2017 - International Taskforce for Prevention of Cardiometabolic Diseases, Aachen, Germany 

Poster (English)

Press Release (English)

Press Release (French)

Press Release (German)

Press Release (Italian)

Press Release (Polish)

Press Release (Spanish)


Tools for change
© 2019 International Diabetes Federation Disclaimer Privacy policy